lateral flow assay
Recently Published Documents


TOTAL DOCUMENTS

522
(FIVE YEARS 278)

H-INDEX

41
(FIVE YEARS 13)

2022 ◽  
Vol 9 ◽  
Author(s):  
Wenzhuang Zhu ◽  
Kaiwen Meng ◽  
Yueping Zhang ◽  
Zhigao Bu ◽  
Dongming Zhao ◽  
...  

African swine fever is a widespread and highly contagious disease in the porcine population, which is caused by African swine fever virus (ASFV). The PCR and ELISA detection methods are the main conventional diagnostic methods for ASFV antigen/antibody detection in the field. However, these methods have limitations of expensive equipment, trained technicians, and time-consuming results. Thus, a rapid, inexpensive, accurate and on-site detection method is urgently needed. Here we describe a double-antigen-sandwich lateral-flow assay based on gold nanoparticle-conjugated ASFV major capsid protein p72, which can detect ASFV antibody in serum samples with high sensitivity and specificity in 10 min and the results can be determined by naked eyes. A lateral flow assay was established by using yeast-expressed and acid-treated ASFV p72 conjugated with gold nanoparticles, which are synthesized by seeding method. A high coincidence (97.8%) of the assay was determined using clinical serum compared to a commercial ELISA kit. In addition, our lateral flow strip can detect as far as 1:10,000 diluted clinically positive serum for demonstration of high sensitivity. In summary, the assay developed here was shown to be rapid, inexpensive, accurate and highly selective. It represents a reliable method for on-site ASFV antibody detection and may help to control the ASFV pandemic.


Biosensors ◽  
2021 ◽  
Vol 12 (1) ◽  
pp. 11
Author(s):  
Zhijian Yi ◽  
Jean de Dieu Habimana ◽  
Omar Mukama ◽  
Zhiyuan Li ◽  
Nelson Odiwuor ◽  
...  

Coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus has led to a global pandemic with a high spread rate and pathogenicity. Thus, with limited testing solutions, it is imperative to develop early-stage diagnostics for rapid and accurate detection of SARS-CoV-2 to contain the rapid transmission of the ongoing COVID-19 pandemic. In this regard, there remains little knowledge about the integration of the CRISPR collateral cleavage mechanism in the lateral flow assay and fluorophotometer. In the current study, we demonstrate a CRISPR/Cas12a-based collateral cleavage method for COVID-19 diagnosis using the Cas12a/crRNA complex for target recognition, reverse transcription loop-mediated isothermal amplification (RT-LAMP) for sensitivity enhancement, and a novel DNA capture probe-based lateral flow strip (LFS) or real-time fluorescence detector as the parallel system readout facility, termed CRICOLAP. Our novel approach uses a customized reporter that hybridizes an optimized complementary capture probe fixed at the test line for naked-eye result readout. The CRICOLAP system achieved ultra-sensitivity of 1 copy/µL in ~32 min by portable real-time fluorescence detection and ~60 min by LFS. Furthermore, CRICOLAP validation using 60 clinical nasopharyngeal samples previously verified with a commercial RT-PCR kit showed 97.5% and 100% sensitivity for S and N genes, respectively, and 100% specificity for both genes of SARS-CoV-2. CRICOLAP advances the CRISPR/Cas12a collateral cleavage result readout in the lateral flow assay and fluorophotometer, and it can be an alternative method for the decentralized field-deployable diagnosis of COVID-19 in remote and limited-resource locations.


Author(s):  
Zahir Ali ◽  
Edith Sánchez ◽  
Muhammad Tehseen ◽  
Ahmed Mahas ◽  
Tin Marsic ◽  
...  

Small Methods ◽  
2021 ◽  
pp. 2101143
Author(s):  
Zhongxing Wang ◽  
Jing Zhao ◽  
Xinxin Xu ◽  
Lingling Guo ◽  
Liguang Xu ◽  
...  

EBioMedicine ◽  
2021 ◽  
Vol 74 ◽  
pp. 103729
Author(s):  
Thomas S. Fulford ◽  
Huy Van ◽  
Nicholas A. Gherardin ◽  
Shuning Zheng ◽  
Marcin Ciula ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document